The Limitations and Promise of Immunotherapy With Chimeric Antigen-Modified T Cells
Oncology (Williston Park)
.
2016 Oct 15;30(10):889-90.
Authors
Raghuveer Ranganathan
,
Matthew C Foster
PMID:
27744646
No abstract available
Publication types
Comment
MeSH terms
Humans
Immunotherapy*
Immunotherapy, Adoptive
Recombinant Fusion Proteins
T-Lymphocytes*
Substances
Recombinant Fusion Proteins